Motilal Oswal BSE Healthcare ETF
Direct · Growth ₹48.07
21 Oct 2026
NAV
24.2%
3Y CAGR
24.5%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
11.74
Sharpe
-16.1%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
0.24%
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹13.46 L | 27.2% | -10.4% | 78.4% |
| 3 Years | ₹36.00 L | ₹46.29 L | 18.6% | 9.2% | 29.2% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | Category avg |
|---|---|---|
| 1 Year | 27.2% | 10.8% |
| 3 Years | 18.6% | 13.9% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 25.5% | 19.6% | -3.9% | 64.2% | 0.96 | 7.98 | 94% | — | — |
| 3 Years | 24.2% | 24.3% | 19.5% | 28.4% | 11.74 | — | 100% | — | — |
-16.1%
Max Drawdown
2 mo
Drawdown Duration
5 mo
Recovery Time
-3.4%
Avg Drawdown
Calmar Ratio by Duration
1.58
1Y
1.50
3Y
118
Total Holdings
56.0%
Top 10 Weight
3
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 14.43% |
| 2 | Dr. Reddy's Laboratories Limited | 5.81% |
| 3 | Apollo Hospitals Enterprise Limited | 5.77% |
| 4 | Divi's Laboratories Limited | 5.76% |
| 5 | Max Healthcare Institute Limited | 5.41% |
| 6 | Cipla Limited | 5.26% |
| 7 | Lupin Limited | 4.26% |
| 8 | Torrent Pharmaceuticals Limited | 3.26% |
| 9 | Fortis Healthcare Limited | 3.15% |
| 10 | Laurus Labs Limited | 2.93% |